US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 268 actively recruiting studies with Colorado sites out of 268 registered in total. The busiest research areas in Colorado are Breast Cancer, Colorectal Cancer, Aging. Leading sponsors running trials in the state include University of Colorado, Denver, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Colorado trials break down as Phase 1 (38), Phase 2 (60), Phase 3 (75), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
268
Recruiting Now
268
← Back to US Map
Top Conditions in Colorado
Breast Cancer (11)Colorectal Cancer (6)Aging (5)Metastatic Breast Cancer (4)Ovarian Cancer (4)Gastric Cancer (4)Esophageal Adenocarcinoma (4)Prostate Cancer (4)Surgery (3)Colorectal Carcinoma (3)Ovarian Carcinoma (3)Colon Cancer (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 268 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 268. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Aging, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT05702138 Phase 2
Recruiting
High Intensity Step Training After Traumatic Brain Injury
Condition
Traumatic Brain Injury
Enrollment
111 pts
Location
United States
Sponsor
Craig Hospital
View Trial →
NCT04718168 N/A
Recruiting
GORE® ENFORM Biomaterial Product Study
Condition
Hernia, Ventral
Enrollment
245 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07498296 N/A
Recruiting
Adapting rHIRE and Sleep Monitoring in Parkinson's Disease
Condition
PARKINSON DISEASE (Disorder)
Enrollment
16 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT06990880 Phase 1, Phase 2
Recruiting
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cance...
Condition
Neoplasms, Prostate
Enrollment
85 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
View Trial →
NCT04652882 Phase 3
Recruiting
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Di...
Condition
Sleep Wake Disorders
Enrollment
70 pts
Location
United States, Austria, Germany
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT02432560 N/A
Recruiting
Safety and Durability of Sirolimus for Treatment of LAM
Condition
Lymphangioleiomyomatosis
Enrollment
600 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT06712654 Phase 2
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in...
Condition
Hyperphosphatemia
Enrollment
168 pts
Location
United States, China
Sponsor
R1 Therapeutics
View Trial →
NCT06193928 N/A
Recruiting
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United Sta...
Condition
Alagille Syndrome
Enrollment
70 pts
Location
United States
Sponsor
Mirum Pharmaceuticals, Inc.
View Trial →
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
View Trial →
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT06689865 N/A
Recruiting
Innovations in Hearing Accessibility and Technology (IHAT) Study
Condition
Hearing Loss
Enrollment
280 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05355701 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Adva...
Condition
Melanoma
Enrollment
267 pts
Location
United States, Canada, Israel
Sponsor
Pfizer
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03767595 N/A
Recruiting
ProACT Post-Approval Study
Condition
Stress Urinary Incontinence
Enrollment
145 pts
Location
United States
Sponsor
Uromedica
View Trial →
NCT07033195 N/A
Recruiting
Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)
Condition
Chronic Pain
Enrollment
200 pts
Location
United States
Sponsor
CognifiSense Inc.
View Trial →
NCT07409181 Phase 2
Recruiting
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic ...
Condition
Systemic Lupus Erythematosus
Enrollment
405 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
Page 4 of 11 — 268 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology